FibroGen Inc (FGEN) — Long-term Investment Intensity
FibroGen Inc (FGEN) has a Long-term Investment Intensity of 2.2% as of September 2025. Long-term investments of $3.04 Million represent 2.2% of total assets of $137.01 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of FibroGen Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
FibroGen Inc Long-term Investment Intensity (2014–2023)
This chart shows how FibroGen Inc's Long-term Investment Intensity has evolved across 10 annual periods from 2014 to 2023. As of September 2025, the intensity stands at 2.2%, reflecting long-term investments of $3.04 Million against total assets of $137.01 Million USD. Also explore FibroGen Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for FibroGen Inc (2014–2023)
The table below presents the year-by-year Long-term Investment Intensity for FibroGen Inc from 2014 to 2023, covering 10 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see FibroGen Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 1.2% | $5.29 Million | $423.53 Million | ▼ -0.3 pp |
| 2022 | 1.5% | $9.41 Million | $610.09 Million | ▼ -20.6 pp |
| 2021 | 22.2% | $171.62 Million | $773.82 Million | ▲ +22.1 pp |
| 2020 | 0.0% | $244.00K | $826.84 Million | ▼ -7.1 pp |
| 2019 | 7.1% | $61.12 Million | $857.40 Million | ▲ +0.8 pp |
| 2018 | 6.3% | $55.82 Million | $880.60 Million | ▲ +5.2 pp |
| 2017 | 1.2% | $10.51 Million | $898.65 Million | ▼ -14.0 pp |
| 2016 | 15.1% | $71.01 Million | $469.55 Million | ▼ -12.9 pp |
| 2015 | 28.0% | $131.72 Million | $470.57 Million | ▼ -1.8 pp |
| 2014 | 29.8% | $144.27 Million | $483.53 Million | — |